This article is retweeted from the Heart Valvular Disease Interventional Therapy Team of West China Hospital.

From February 14th to 17th, 2019, the top-class International Conference on Valvular Disease-the 2019 PCR Tokyo valveswas held in Tokyo, Janpan. As the director of the Cardiology department of West China Hospital of Sichuan University and the vice president of Sichuan International Medical Exchange&Promotion Association,professor Chen Mao was invited as the only executive chairman of the conference from China attended the conference and conduct improtant academic reports.

As the most influential valve conference in the Asia-Pacific region, this conference has attracted thousands of experts in the field of valve disease from more than 20 countries.  As the co-executive chairman of the conference, Professor Chen Mao commented on the treatment of difficult TAVI cases, the application of TAVI treatment in the two-leaf aortic stenosis,and the pre-image evaluation of TAVI and conducted important cademic exchanges. Among numerous teartment stategies,the "Reshaping"TAVI proposed by the minimally invasive treatment team of West China Hospital for Valvular Heart Disease ,was  further recognized by the guest and got enthusiatical respond from the participating experts. 

   This conferrence is one of the three flagship conference in the feild of international valvular disease. What's more, the other two are the Chengdu International Heart Valve Disease Interventional Therapy Conference hosted by the Cardiology Department of West China Hospital and the London Valve Conference. These three conferences were laid out one after another, linking and builting the communication bridge amnong Europe, America and Asia Pacific in the field of minimanlly invasive treatment of heart valve disease. And Professor Chen Mao, as one of the major international experts in PCR, particopating in promoting the global development of valvular minimally invasive treatment positively .   The successful participation of Professor Chen Mao highlights the international influence of West China Hospital TAVI technology and propels the stable development of minimally invasive treatment for valvular disease of West China Hospital.